In conclusion, our present studies suggest that multi-kinase inhibitors of ROCK and MRCK (DJ4 and DJ110) effectively block cancer cell migration and cell survival better than selective ROCK inhibitors (DJE4, DJ-Allyl, and DJ-Morpholine). The gene discussed is CDC42BPA; the disease is cancer.